A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's—tau protein and beta-amyloid ...
The National Institutes of Health reports that incidences of Alzheimer’s disease and other dementia increased by roughly 148 ...
Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...
Parkinson’s dementia, vascular dementia and frontotemporal dementia—the condition affecting both Bruce Willis and Wendy ...
II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...
Gain Therapeutics, Inc.’s GANX share price has surged by 10.41%, which has investors questioning if this is right time to sell.
It warns: "You need to tell DVLA about some medical conditions as they can affect your driving. You can be fined up to £1,000 ...
The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections ...
Two Fountain Hills women are working to make their town "dementia friendly" so that other caretakers know that they are not alone.
More about lecanemab More about donanemab When people can be diagnosed in the earlier stages of dementia and access new disease-modifying treatments, the typical pattern of decline experienced by ...
Among patients with iRBD, altered visuospatial cue-elicited N2 and P3 ERPs predicted phenoconversion to α-synucleinopathies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback